682 related articles for article (PubMed ID: 12667566)
1. Comparison of arrhythmia recurrence in patients presenting with ventricular fibrillation versus ventricular tachycardia in the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial.
Raitt MH; Klein RC; Wyse DG; Wilkoff BL; Beckman K; Epstein AE; Coromilas J; Friedman PL; Martins J; Ledingham RB; Greene HL;
Am J Cardiol; 2003 Apr; 91(7):812-6. PubMed ID: 12667566
[TBL] [Abstract][Full Text] [Related]
2. Follow-up of patients with unexplained syncope and inducible ventricular tachyarrhythmias: analysis of the AVID registry and an AVID substudy. Antiarrhythmics Versus Implantable Defibrillators.
Steinberg JS; Beckman K; Greene HL; Marinchak R; Klein RC; Greer SG; Ehlert F; Foster P; Menchavez E; Raitt M; Wathen MS; Morris M; Hallstrom A
J Cardiovasc Electrophysiol; 2001 Sep; 12(9):996-1001. PubMed ID: 11573709
[TBL] [Abstract][Full Text] [Related]
3. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
[TBL] [Abstract][Full Text] [Related]
4. Patients at lower risk of arrhythmia recurrence: a subgroup in whom implantable defibrillators may not offer benefit. Antiarrhythmics Versus Implantable Defibrillator (AVID) Trial Investigators.
Hallstrom AP; McAnulty JH; Wilkoff BL; Follmann D; Raitt MH; Carlson MD; Gillis AM; Shih HT; Powell JL; Duff H; Halperin BD;
J Am Coll Cardiol; 2001 Mar; 37(4):1093-9. PubMed ID: 11263614
[TBL] [Abstract][Full Text] [Related]
5. Analysis of implantable cardioverter defibrillator therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial.
Klein RC; Raitt MH; Wilkoff BL; Beckman KJ; Coromilas J; Wyse DG; Friedman PL; Martins JB; Epstein AE; Hallstrom AP; Ledingham RB; Belco KM; Greene HL;
J Cardiovasc Electrophysiol; 2003 Sep; 14(9):940-8. PubMed ID: 12950538
[TBL] [Abstract][Full Text] [Related]
6. Clinical and electrophysiologic predictors of ventricular tachyarrhythmia recurrence in patients with implantable cardioverter defibrillators.
Gillis AM; Sheldon RS; Wyse DG; Duff HJ; Cassidy MR; Mitchell LB
J Cardiovasc Electrophysiol; 2003 May; 14(5):492-8. PubMed ID: 12776866
[TBL] [Abstract][Full Text] [Related]
7. Beta-blocker use and survival in patients with ventricular fibrillation or symptomatic ventricular tachycardia: the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial.
Exner DV; Reiffel JA; Epstein AE; Ledingham R; Reiter MJ; Yao Q; Duff HJ; Follmann D; Schron E; Greene HL; Carlson MD; Brodsky MA; Akiyama T; Baessler C; Anderson JL
J Am Coll Cardiol; 1999 Aug; 34(2):325-33. PubMed ID: 10440140
[TBL] [Abstract][Full Text] [Related]
8. Ventricular arrhythmias detected after transvenous defibrillator implantation in patients with a clinical history of only ventricular fibrillation. Implications for use of implantable defibrillator.
Raitt MH; Dolack GL; Kudenchuk PJ; Poole JE; Bardy GH
Circulation; 1995 Apr; 91(7):1996-2001. PubMed ID: 7895358
[TBL] [Abstract][Full Text] [Related]
9. Electrical storm presages nonsudden death: the antiarrhythmics versus implantable defibrillators (AVID) trial.
Exner DV; Pinski SL; Wyse DG; Renfroe EG; Follmann D; Gold M; Beckman KJ; Coromilas J; Lancaster S; Hallstrom AP;
Circulation; 2001 Apr; 103(16):2066-71. PubMed ID: 11319196
[TBL] [Abstract][Full Text] [Related]
10. Ventricular tachycardia during follow-up in patients resuscitated from ventricular fibrillation: experience from stored electrograms of implantable cardioverter-defibrillators.
Rüppel R; Schlüter CA; Boczor S; Meinertz T; Schlüter M; Kuck KH; Cappato R
J Am Coll Cardiol; 1998 Nov; 32(6):1724-30. PubMed ID: 9822102
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.
Daubert JP; Zareba W; Hall WJ; Schuger C; Corsello A; Leon AR; Andrews ML; McNitt S; Huang DT; Moss AJ;
J Am Coll Cardiol; 2006 Jan; 47(1):98-107. PubMed ID: 16386671
[TBL] [Abstract][Full Text] [Related]
12. Gender differences in ventricular arrhythmia recurrence in patients with coronary artery disease and implantable cardioverter-defibrillators.
Lampert R; McPherson CA; Clancy JF; Caulin-Glaser TL; Rosenfeld LE; Batsford WP
J Am Coll Cardiol; 2004 Jun; 43(12):2293-9. PubMed ID: 15193696
[TBL] [Abstract][Full Text] [Related]
13. Postoperative ventricular arrhythmias after cardiac surgery: immediate- and long-term significance.
Brembilla-Perrot B; Villemot JP; Carteaux JP; Haouzi A; Amrein D; Schöth B; Houriez P; Beurrier D; Djaballah K; Vançon AC; Nippert M
Pacing Clin Electrophysiol; 2003 Feb; 26(2 Pt 1):619-25. PubMed ID: 12710323
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of baseline electrophysiology studies in patients with sustained ventricular tachyarrhythmia: the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial.
Brodsky MA; Mitchell LB; Halperin BD; Raitt MH; Hallstrom AP;
Am Heart J; 2002 Sep; 144(3):478-84. PubMed ID: 12228785
[TBL] [Abstract][Full Text] [Related]
15. The effect of spironolactone on ventricular tachyarrhythmias in patients with implantable cardioverter-defibrillators.
Zarraga IG; Dougherty CM; MacMurdy KS; Raitt MH
Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):739-47. PubMed ID: 22773022
[TBL] [Abstract][Full Text] [Related]
16. Antiarrhythmic drug use in the implantable defibrillator arm of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Study.
Steinberg JS; Martins J; Sadanandan S; Goldner B; Menchavez E; Domanski M; Russo A; Tullo N; Hallstrom A;
Am Heart J; 2001 Sep; 142(3):520-9. PubMed ID: 11526368
[TBL] [Abstract][Full Text] [Related]
17. Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias. AVID Investigators. Antiarrhythmics Versus Implantable Defibrillators.
Domanski MJ; Sakseena S; Epstein AE; Hallstrom AP; Brodsky MA; Kim S; Lancaster S; Schron E
J Am Coll Cardiol; 1999 Oct; 34(4):1090-5. PubMed ID: 10520795
[TBL] [Abstract][Full Text] [Related]
18. Differences in amiodarone efficacy in relation to ejection fraction and basal rhythm in patients with implantable cardioverter defibrillators.
Watanabe T; Inoue K; Kashiwase K; Mine T; Hirooka K; Shutta R; Mizuno H; Okuyama Y; Sakata Y; Nanto S;
J Electrocardiol; 2018; 51(6):1111-1115. PubMed ID: 30497740
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic decision tree for patients with sustained ventricular tachyarrhythmias or aborted cardiac arrest: a critical review of the Antiarrhythmics Versus Implantable Defibrillator trial and the Canadian Implantable Defibrillator Study.
Farré J; Cabrera JA; Romero J; Rubio JM
Am J Cardiol; 2000 Nov; 86(9A):44K-51K. PubMed ID: 11084100
[TBL] [Abstract][Full Text] [Related]
20. Initial clinical experience with a new arrhythmia detection algorithm in dual chamber implantable cardioverter defibrillators.
Theuns D; Klootwijk AP; Kimman GP; Szili-Török T; Roelandt JR; Jordaens L
Europace; 2001 Jul; 3(3):181-6. PubMed ID: 11467458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
